|
|
|
Insider
Information: |
Fouse Jacqualyn A |
Relationship: |
Director |
City: |
White Plains |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
288,702 |
|
Indirect Shares
|
1,448 |
|
|
Direct
Value |
$24,512,124 |
|
|
Indirect Value
|
$156,732 |
|
|
Total
Shares |
290,150 |
|
|
Total
Value |
$24,668,856 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
6.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bunge Ltd |
BG |
Chief Financial Officer |
2010-09-02 |
0 |
2007-07-23 |
0 |
Premium* |
|
Celgene Corp |
CELG |
see remarks, Director |
2016-12-02 |
82,040 |
2016-12-02 |
1,448 |
Premium* |
|
Dicks Sporting Goods Inc |
DKS |
Director |
2020-03-22 |
55,288 |
2011-03-15 |
0 |
Premium* |
|
Perrigo Co |
PRGO |
Director |
2013-12-18 |
0 |
2012-11-14 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
13,978 |
2018-03-29 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-04-10 |
137,396 |
2019-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
103 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DKS |
Dicks Sporting Goods Inc |
Director |
|
2020-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
9,518 |
55,288 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-12-17 |
4 |
D |
$112.17 |
$396,184 |
D/D |
(3,532) |
58,079 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-02-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,398) |
58,363 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,200 |
59,403 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2015-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
61,611 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,333 |
61,761 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-02-14 |
4 |
D |
$30.50 |
$106,903 |
D/D |
(3,505) |
66,192 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,334 |
69,697 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-02-12 |
4 |
D |
$102.45 |
$1,408,278 |
D/D |
(13,746) |
73,569 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-02-22 |
4 |
D |
$29.08 |
$106,840 |
D/D |
(3,674) |
74,897 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,379 |
78,571 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-04-29 |
4 |
D |
$103.41 |
$535,354 |
D/D |
(5,177) |
79,392 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-12-02 |
4 |
D |
$117.63 |
$276,666 |
D/D |
(2,352) |
82,040 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-02-16 |
4 |
D |
$28.91 |
$105,464 |
D/D |
(3,648) |
82,582 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
84,392 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,000 |
84,569 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,333 |
86,230 |
0 |
- |
|
CELG |
Celgene Corp |
see remarks |
|
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
29,219 |
87,315 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-04-12 |
4 |
D |
$21.35 |
$101,007 |
D/D |
(4,731) |
93,784 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,933 |
98,515 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-06-30 |
4 |
S |
$28.36 |
$303,962 |
D/D |
(10,718) |
106,966 |
0 |
% |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-01-09 |
4 |
AS |
$22.99 |
$192,909 |
D/D |
(8,391) |
116,075 |
0 |
% |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,900 |
117,684 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
124,466 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2024-01-24 |
4 |
AS |
$21.64 |
$232,024 |
D/D |
(10,722) |
129,253 |
0 |
% |
|
103 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|